Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
Current SymbolNASDAQ:CTRX
Previous SymbolNASDAQ:SXCI
CUSIP14888710
Phone+1-800-2823232
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Catamaran (NASDAQ:CTRX) Frequently Asked Questions
What is Catamaran's stock symbol?
Catamaran trades on the NASDAQ under the ticker symbol "CTRX."
How were Catamaran's earnings last quarter?
Catamaran Corp (NASDAQ:CTRX) announced its quarterly earnings data on Thursday, February, 26th. The healthcare company reported $0.67 earnings per share for the quarter, beating analysts' consensus estimates of $0.61 by $0.06. The healthcare company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.57 billion. The company's quarterly revenue was up 26.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.56 EPS. View Catamaran's Earnings History.
Has Catamaran been receiving favorable news coverage?
Media headlines about CTRX stock have trended neutral this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Catamaran earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news stories about the healthcare company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Catamaran?
Shares of CTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Catamaran's official website?
How can I contact Catamaran?
Catamaran's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The healthcare company can be reached via phone at +1-800-2823232.
MarketBeat Community Rating for Catamaran (NASDAQ CTRX)
MarketBeat's community ratings are surveys of what our community members think about Catamaran and other stocks. Vote "Outperform" if you believe CTRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
